| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, Global Head Of R&D | Global Head Of R&D
1 company
Wang Lai is a President, Global Head Of R&D at BeOne Medicines Ltd.. Recent SEC Form 4 filings include 0 buys and 14 sells.
Estimated insider holdings value: $392.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 26, 2023 | ONC Beone Medicines Ltd. | Global Head Of R&D | Sell | 1,108 | $181.92 | $201,567.33 | -99.6% | +5.7% | -16.2% | |
| Jun 20, 2023 | ONC Beone Medicines Ltd. | Global Head Of R&D | Sell | 1,325 | $192.42 | $254,955.44 | -100% | +9.1% | -18.8% | |
| Jun 7, 2023 | ONC Beone Medicines Ltd. | Global Head Of R&D | Sell | 462 | $224.74 | $103,828.48 | -38.7% | -8.7% | -29.8% | |
| Jun 27, 2022 | ONC Beone Medicines Ltd. | Global Head Of R&D | Sell | 458 | $177.32 | $81,214.71 | -100% | -23.0% | +5.3% | |
| Jun 21, 2022 | ONC Beone Medicines Ltd. | Global Head Of R&D | Sell | 1,168 | $145.35 | $169,767.41 | -61.8% | +1.4% | +21.6% | |
| Jun 6, 2022 | ONC Beone Medicines Ltd. | Global Head Of R&D | Sell | 660 | $142.00 | $93,717.56 | -100% | +18.1% | +63.4% | |
| Jun 28, 2021 | ONC Beone Medicines Ltd. | Global Head Of R&D | Sell | 455 | $362.48 | $164,929.95 | -100% | +5.4% | -53.9% | |
| Jun 18, 2021 | ONC Beone Medicines Ltd. | Global Head Of R&D | Sell | 802 | $331.15 | $265,583.18 | -100% | +19.7% | -58.9% | |
| Jun 7, 2021 | ONC Beone Medicines Ltd. | Global Head Of R&D | Sell | 656 | $354.26 | $232,392.33 | -100% | +0.7% | -55.1% |